A message from the Co-Editor-in-Chief
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-06-01
|
Series: | Acta Pharmaceutica Sinica B |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211383521001921 |
id |
doaj-367721645b8c48ecb0ebfdde2abffa40 |
---|---|
record_format |
Article |
spelling |
doaj-367721645b8c48ecb0ebfdde2abffa402021-06-25T04:48:14ZengElsevierActa Pharmaceutica Sinica B2211-38352021-06-011161364A message from the Co-Editor-in-ChiefXinxin Ding0Co-Editor-in-Chief of APSBhttp://www.sciencedirect.com/science/article/pii/S2211383521001921 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Xinxin Ding |
spellingShingle |
Xinxin Ding A message from the Co-Editor-in-Chief Acta Pharmaceutica Sinica B |
author_facet |
Xinxin Ding |
author_sort |
Xinxin Ding |
title |
A message from the Co-Editor-in-Chief |
title_short |
A message from the Co-Editor-in-Chief |
title_full |
A message from the Co-Editor-in-Chief |
title_fullStr |
A message from the Co-Editor-in-Chief |
title_full_unstemmed |
A message from the Co-Editor-in-Chief |
title_sort |
message from the co-editor-in-chief |
publisher |
Elsevier |
series |
Acta Pharmaceutica Sinica B |
issn |
2211-3835 |
publishDate |
2021-06-01 |
url |
http://www.sciencedirect.com/science/article/pii/S2211383521001921 |
work_keys_str_mv |
AT xinxinding amessagefromthecoeditorinchief AT xinxinding messagefromthecoeditorinchief |
_version_ |
1721360596350271488 |